ICCC vs TRV · rev $26.5M vs P/E 14, rev $48.83B
ImmuCell Corporation (ICCC) versus The Travelers Companies Inc (TRV) — a side-by-side from cached financials, not a winner call.
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
The Travelers Companies Inc (TRV) is a insurance - property & casualty company listed on US.
Latest reported ICCC revenue for 2024-12-31 was $26.5M. Net income was -$2.2M. Revenue was up 51.6% from 2023-12-31 to 2024-12-31. ICCC currently screens at market cap $58.9M.
Latest reported TRV revenue for 2025-12-31 was $48.83B. Net income was $6.29B. Revenue was up 5.2% from 2024-12-31 to 2025-12-31. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
ICCC currently screens at market cap $58.9M. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
Not investment advice. Open the ICCC and TRV stock pages for the full models.
Not investment advice.